A letter in the BMJ

References: Davies J, Moncrieff J, Kinderman P, et al; Council for Evidence-Based Psychiatry. Stigma and efficacy of taking antidepressants. Letter to the editor. Times 2018 Feb 23. Burns W. Pills for … Continue reading A letter in the BMJ

Selective Serotonin Reuptake Inhibitors

This perspective was published in the BMJ in 2004. It was written by: The authors began: The authors concluded: 15 years on and both these academics remain firmly at the … Continue reading Selective Serotonin Reuptake Inhibitors

It’s BOOM time in Industry

This is an unedited clip of a contribution made by Professor Michael Sharpe, Professor of Psychological Medicine at the University of Oxford. The Event marked the 50th Anniversary of the … Continue reading It’s BOOM time in Industry

Tapering SSRI treatment to mitigate withdrawal symptoms

This Personal View by Mark Abie Horowitz and David Taylor has been published in this month’s Lancet. I have written to the authors to thank them for providing this sensible … Continue reading Tapering SSRI treatment to mitigate withdrawal symptoms

“And the Gordon Bennett Trophy goes to . . .”

It is likely that you will know the phrase “Gordon Bennett” as an expression of incredulity. But who was Gordon Bennett? And why is he remembered in this way? James … Continue reading “And the Gordon Bennett Trophy goes to . . .”

Values

The following film is an expression of my reasons for having resigned from the Royal College of Psychiatrists. I took this decision after a lot of reflection about what is … Continue reading Values

University of Oxford – Department of Psychiatry

This is the third in a series of posts that seeks to examine British academia’s “strategic partnerships with industry”. The following slideshow shares some of the University of Oxford, Department of Psychiatry’s ‘strategic … Continue reading University of Oxford – Department of Psychiatry

‘Compelling evidence for maintenance treatment for antidepressants’

Dr David Christmas, 27 April 2017: “With regards to evidence, there is compelling evidence of benefit for maintenance treatment for antidepressants for at least 3 years (Geddes et al, 2003). … Continue reading ‘Compelling evidence for maintenance treatment for antidepressants’

Antidepressant prescribing and informed consent

I have submitted the following to the BMJ in response to this research news: Large meta-analysis ends doubts about efficacy of antidepressants In Scotland, it is estimated that 1 in … Continue reading Antidepressant prescribing and informed consent